Literature DB >> 17112231

Comparison of p53 mutations induced by PAH o-quinones with those caused by anti-benzo[a]pyrene diol epoxide in vitro: role of reactive oxygen and biological selection.

Yu-Min Shen1, Andrea B Troxel, Srilakshmi Vedantam, Trevor M Penning, Jeffrey Field.   

Abstract

Polycyclic aromatic hydrocarbons (PAH) are one of the major carcinogens in tobacco smoke. They are metabolically activated through different routes to form either diol-epoxides, PAH o-quinones, or radical cations, each of which has been proposed to be an ultimate carcinogen. To study how PAH metabolites mutate p53, we used a yeast reporter gene assay based on p53 transcriptional activity. Colonies expressing wt p53 turn white (ADE +) and those expressing mutant p53 turn red (ADE -). We examined the mutagenicity of three o-quinones, benzo[a]pyrene-7,8-dione, benz[a]anthracene-3,4-dione, and dimethylbenz[a]anthracene-3,4-dione, and compared them with (+/-)-anti-benzo[a]pyrene diol epoxide ((+/-)-anti-BPDE) within the same system. The PAH o-quinones tested gave a dose-dependent increase in mutation frequency in the range of 0.160-0.375 microM quinone, provided redox-cycling conditions were used. The dominant mutations were G to T transversions (>42%), and the incidence of hotspot mutations in the DNA-binding domain was more than twice than that expected by a random distribution. The dependence of G to T transversions on redox cycling implicates 8-oxo-dGuo as the lesion responsible, which is produced under identical conditions (Chem. Res. Toxicol. (2005) 18, 1027). A dose-dependent mutation frequency was also observed with (+/-)-anti-BPDE but at micromolar concentrations (0-20 microM). The mutation pattern observed was G to C (63%) > G to A (18%) > G to T (15%) in umethylated p53 and was G to A (39%) > G to C (34%) > G to T (16%) in methylated p53. The preponderance of G mutations is consistent with the formation of anti-BPDE-N2-dGuo as the major adduct. The frequency of hotspots mutated by (+/-)-anti-BPDE was essentially random in umethylated and methylated p53, suggesting that 5'-CpG-3' islands did not direct mutations in the assay. These data suggest that smoking may cause mutations in p53 by formation of PAH o-quinones, which produce reactive oxygen species. The resultant 8-oxo-dGuo yields a pattern of mutations but not a spectrum consistent with that seen in lung cancer; we suggest that the emergence of the spectrum requires biological selection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17112231      PMCID: PMC2366885          DOI: 10.1021/tx0601206

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  47 in total

1.  Dominant-negative p53 mutations selected in yeast hit cancer hot spots.

Authors:  R K Brachmann; M Vidal; J D Boeke
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

Review 2.  Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activation: generation of reactive and redox active o-quinones.

Authors:  T M Penning; M E Burczynski; C F Hung; K D McCoull; N T Palackal; L S Tsuruda
Journal:  Chem Res Toxicol       Date:  1999-01       Impact factor: 3.739

3.  Cytosine methylation determines hot spots of DNA damage in the human P53 gene.

Authors:  M F Denissenko; J X Chen; M S Tang; G P Pfeifer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

4.  A mammalian DNA repair enzyme that excises oxidatively damaged guanines maps to a locus frequently lost in lung cancer.

Authors:  R Lu; H M Nash; G L Verdine
Journal:  Curr Biol       Date:  1997-06-01       Impact factor: 10.834

5.  Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7, 8-dihydroxy-7,8-dihydrobenzo[a]pyrene to the activated o-quinone metabolite benzo[a]pyrene-7,8-dione.

Authors:  M E Burczynski; R G Harvey; T M Penning
Journal:  Biochemistry       Date:  1998-05-12       Impact factor: 3.162

6.  Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.

Authors:  T Shimada; C L Hayes; H Yamazaki; S Amin; S S Hecht; F P Guengerich; T R Sutter
Journal:  Cancer Res       Date:  1996-07-01       Impact factor: 12.701

7.  p53 gene mutation: software and database.

Authors:  C Béroud; T Soussi
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

8.  Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme.

Authors:  M Marutani; H Tonoki; M Tada; M Takahashi; H Kashiwazaki; Y Hida; J Hamada; M Asaka; T Moriuchi
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

9.  Expanded analysis of benzo[a]pyrene-DNA adducts formed in vitro and in mouse skin: their significance in tumor initiation.

Authors:  L Chen; P D Devanesan; S Higginbotham; F Ariese; R Jankowiak; G J Small; E G Rogan; E L Cavalieri
Journal:  Chem Res Toxicol       Date:  1996 Jul-Aug       Impact factor: 3.739

10.  Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53.

Authors:  M F Denissenko; A Pao; M Tang; G P Pfeifer
Journal:  Science       Date:  1996-10-18       Impact factor: 47.728

View more
  18 in total

1.  Calcium, vitamin D, VDR genotypes, and epigenetic and genetic changes in rectal tumors.

Authors:  Martha L Slattery; Roger K Wolff; Jennifer S Herrick; Bette J Caan; Wade Samowitz
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  Alcohol consumption and rectal tumor mutations and epigenetic changes.

Authors:  Martha L Slattery; Roger K Wolff; Jennifer S Herrick; Karen Curtin; Bette J Caan; Wade Samowitz
Journal:  Dis Colon Rectum       Date:  2010-08       Impact factor: 4.585

3.  Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy.

Authors:  Ankita Kumari; Charu Bahl; Navneet Singh; Digambar Behera; Siddharth Sharma
Journal:  Mol Biol Rep       Date:  2016-09-10       Impact factor: 2.316

4.  Aldo-keto reductases protect lung adenocarcinoma cells from the acute toxicity of B[a]P-7,8-trans-dihydrodiol.

Authors:  Zahidur Abedin; Sushmita Sen; Jeffrey Field
Journal:  Chem Res Toxicol       Date:  2011-11-16       Impact factor: 3.739

5.  Detoxication of structurally diverse polycyclic aromatic hydrocarbon (PAH) o-quinones by human recombinant catechol-O-methyltransferase (COMT) via O-methylation of PAH catechols.

Authors:  Li Zhang; Yi Jin; Mo Chen; Meng Huang; Ronald G Harvey; Ian A Blair; Trevor M Penning
Journal:  J Biol Chem       Date:  2011-05-27       Impact factor: 5.157

6.  The pattern of p53 mutations caused by PAH o-quinones is driven by 8-oxo-dGuo formation while the spectrum of mutations is determined by biological selection for dominance.

Authors:  Jong-Heum Park; Stacy Gelhaus; Srilakshmi Vedantam; Andrea L Oliva; Abhita Batra; Ian A Blair; Andrea B Troxel; Jeffrey Field; Trevor M Penning
Journal:  Chem Res Toxicol       Date:  2008-05       Impact factor: 3.739

Review 7.  Polycyclic aromatic hydrocarbons and esophageal squamous cell carcinoma.

Authors:  Gholamreza Roshandel; Shahryar Semnani; Reza Malekzadeh; Sanford M Dawsey
Journal:  Arch Iran Med       Date:  2012-11       Impact factor: 1.354

8.  Metabolism of benzo[a]pyrene in human bronchoalveolar H358 cells using liquid chromatography-mass spectrometry.

Authors:  Hao Jiang; Stacy L Gelhaus; Dipti Mangal; Ronald G Harvey; Ian A Blair; Trevor M Penning
Journal:  Chem Res Toxicol       Date:  2007-08-17       Impact factor: 3.739

9.  Association between p53 codon 72 genetic polymorphism and tobacco use and lung cancer risk.

Authors:  Dante D Cáceres; Luis A Quiñones; Jane C Schroeder; Leonel D Gil; Carlos E Irarrázabal
Journal:  Lung       Date:  2009-01-07       Impact factor: 2.584

10.  The role of base excision repair genes OGG1, APN1 and APN2 in benzo[a]pyrene-7,8-dione induced p53 mutagenesis.

Authors:  Zahidur Abedin; Melissa Louis-Juste; Melissa Stangl; Jeffrey Field
Journal:  Mutat Res       Date:  2012-10-29       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.